The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Dysbiosis of gut microbiota in promoting the development of colorectal cancer
Open accessAbstract
Gastrointestinal microbiome, containing at least 100 trillion bacteria, resides in the mucosal surface of human intestine. Recent studies show that perturbations in the microbiota may influence physiology and link to a number of diseases, including colon tumorigenesis. Colorectal cancer (CRC), the third most common cancer, is the disease resulting from multi-genes and multi-factors, but the mechanistic details between gut microenvironment and CRC remain poorly characterized. Thanks to new technologies such as metagenome sequencing, progress in large-scale analysis of the genetic and metabolic profile of gut microbial has been possible, which has facilitated studies about microbiota composition, taxonomic alterations and host interactions. Different bacterial species and their metabolites play critical roles in the development of CRC. Also, microbiota is important in the inflammatory response and immune processes deregulation during the development and progression of CRC. This review summarizes current studies regarding the association between gastrointestinal microbiota and the development of CRC, which provides insights into the therapeutic strategy of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 2×
“Dietary supplementation of mice with TMAO promotes atherosclerosis [153].”
BackgroundRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 2×
“In addition, it is shown that Bifidobacterium administration plus programmed cell death protein ligand 1 (PD-L1)-specific antibody therapy can block melanoma tumor growth in mouse models [60].”
BackgroundAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 1×
“It was shown that increased gut bacteria Bacteroidetes phylum is related to the host’s response to the treatment of immunologic checkpoint blockade with monoclonal antibody ipilimumab [102], which blocks cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4, a major negative regulator of T-cell activation) signaling [10…”
BackgroundIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 3×
“nucleatum can induce carcinogenesis through the inflammatory nuclear factor-kappab (NF-kb) signaling pathway and by down-regulating anti-tumor T cell-mediated adaptive immunity [32,34,35].”
BackgroundRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368 · cited 2×
“They bind to GPR109A (Niacr1), a receptor for butyrate and niacin, to suppress intestinal inflammation and carcinogenesis [158], thereby Gut microbiota and colorectal cancer | 7”
BackgroundThe gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302 · cited 1×
“The microbiome can work with the host to promote health but can sometimes initiate or promote disease [11,17,9].”
BackgroundIntestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
The Long-Term Stability of the Human Gut Microbiota
Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A. L., Clemente, J. C., Knight, R., Heath, A. C., Leibel, R. L., et al. (2013) · Science · doi:10.1126/science.1237439 · Cited by 2,058
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The history of toll-like receptors - redefining innate immunity
O'Neill, L. A. J., Golenbock, D., & Bowie, A. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3446 · Cited by 1,765
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y. S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.001 · Cited by 1,731
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota
Round, J. L., Lee, S. M., Li, J., Tran, G., Jabri, B., Chatila, T. A., & Mazmanian, S. K. (2011) · Science · doi:10.1126/science.1206095 · Cited by 1,604
Gut microbiome development along the colorectal adenoma-carcinoma sequence
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506 · cited 1×
“Recently, metagenome-wide association studies on fecal samples have characterized microbial markers of CRC [7,8].”
BackgroundGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490 · cited 1×
“nucleatum can associate with TIGIT, an inhibitory receptor present on natural killer (NK) cells and T cells, to inhibit NK cell cytotoxicity [36].”
BackgroundBile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288 · cited 1×
“There are two important TLR pathways: one dependent on myeloid differentiation factor 88 (MyD88) adaptor proteins and the other a TRIF-dependent pathway [86,87].”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Yu, J., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309800 · Cited by 1,253
Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra-Rojas, I., Martínez-Hernández, N. E., Márquez-Sandoval, Y. F., Illades-Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,196
Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188
Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2359 · Cited by 1,156
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310101 · Cited by 1,080 · cited 3×
“nucleatum DNA is associated with shorter survival in CRC patients [30].”
BackgroundAlleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Dubin, K., Callahan, M. K., Ren, B., Khanin, R., Viale, A., Ling, L., No, D., Gobourne, A., Littmann, E., Huttenhower, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms10391 · Cited by 987 · cited 1×
“It was shown that increased gut bacteria Bacteroidetes phylum is related to the host’s response to the treatment of immunologic checkpoint blockade with monoclonal antibody ipilimumab [102], which blocks cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4, a major negative regulator of T-cell activation) signaling [10…”
BackgroundHuman Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914
Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations
Thaiss, C. A., Levy, M., Korem, T., Dohnalová, L., Shapiro, H., Jaitin, D. A., David, E., Winter, D. R., Gury-BenAri, M., Tatirovsky, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.003 · Cited by 870
Gut microbiota imbalance and colorectal cancer
Gagnière, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.501 · Cited by 845
Microbes, Microbiota, and Colon Cancer
Sears, C. L., & Garrett, W. S. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.007 · Cited by 818
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 716
Microbiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
The contributory role of gut microbiota in cardiovascular disease
Tang, W. H. W., & Hazen, S. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72331 · Cited by 641
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu787 · Cited by 625 · cited 1×
“In addition, murine experiments have demonstrated the crucial roles of BFT and the Th17/IL-17 axis in ETBF carcinogenesis [52], which could promote the differentiation of”
BackgroundDiet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues
Krautkramer, K. A., Kreznar, J. H., Romano, K. A., Vivas, E. I., Barrett-Wilt, G. A., Rabaglia, M. E., Keller, M. P., Attie, A. D., Rey, F. E., & Denu, J. M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.025 · Cited by 607
Strauss, J., Kaplan, G. G., Beck, P. L., Rioux, K., Panaccione, R., DeVinney, R., Lynch, T., & Allen-Vercoe, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21606 · Cited by 573
Annual report on status of cancer in China, 2010
Wanqing, Chen, Rongshou, Zheng, Z., Siwei, Zhang, Ping, P., Zhao, Hongmei, Zeng, et al. (2014) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 565
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541 · cited 1×
“Emerging evidence has shown that the dysbiosis of gut microbiota can lead to alteration of the host physiology, resulting in the pathogenic processes of different diseases [18, 19].”
BackgroundHigh Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535 · cited 2×
“coli strains of the B2 phylogroup favored the colonization of colon cancer [44].”
BackgroundA catalog of the mouse gut metagenome
Xiao, L., Feng, Q., Liang, S., Sonne, S. B., Xia, Z., Qiu, X., Li, X., Long, H., Zhang, J., Zhang, D., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3353 · Cited by 520
Inan, M. S., Rasoulpour, R. J., Yin, L., Hubbard, A. K., Rosenberg, D. W., & Giardina, C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70142-9 · Cited by 499
Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0932 · Cited by 478
Bile acid nuclear receptor FXR and digestive system diseases
Ding, L., Yang, L., Wang, Z., & Huang, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.004 · Cited by 477
Colonization of the Human Gut by E. coli and Colorectal Cancer Risk
Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D., & Darfeuille-Michaud, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1343 · Cited by 475
Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells
Belcheva, A., Irrazabal, T., Robertson, S. J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E. H., Copeland, J. K., Surendra, A., Kumar, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.051 · Cited by 473
Probiotics, gut microbiota and health
Butel, M.-J. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.10.002 · Cited by 457
Beyond intestinal soap—bile acids in metabolic control
Kuipers, F., Bloks, V. W., & Groen, A. K. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.60 · Cited by 454
Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
Loddo, I., & Romano, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00551 · Cited by 449
Human Insulin Resistance Is Associated With Increased Plasma Levels of 12α-Hydroxylated Bile Acids
Haeusler, R. A., Astiarraga, B., Camastra, S., Accili, D., & Ferrannini, E. (2013) · Diabetes · doi:10.2337/db13-0639 · Cited by 444
A functional role for NLRP6 in intestinal inflammation and tumorigenesis
Chen, G. Y., Liu, M., Wang, F., Bertin, J., & Núñez, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100412 · Cited by 436
Lopez-Siles, M., Khan, T. M., Duncan, S. H., Harmsen, H. J. M., Garcia-Gil, L. J., & Flint, H. J. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06858-11 · Cited by 433 · cited 1×
“Faecalibacterium prausnitzii # Generating butyrate [164]”
Kummen, M., Holm, K., Anmarkrud, J. A., Nygård, S., Vesterhus, M., Høivik, M. L., Trøseid, M., Marschall, H.-U., Schrumpf, E., Moum, B., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310500 · Cited by 426
Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation
Wu, S., Morin, P. J., Maouyo, D., & Sears, C. L. (2003) · Gastroenterology · doi:10.1053/gast.2003.50047 · Cited by 393
Arthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fodor, A. A., & Jobin, C. (2014) · Nature Communications · doi:10.1038/ncomms5724 · Cited by 392
Secondary bile acids: an underrecognized cause of colon cancer
Ajouz, H., Mukherji, D., & Shamseddine, A. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-164 · Cited by 374
Annual report on status of cancer in China, 2011.
Chen, W., Zheng, R., Zeng, H., Zhang, S., & He, J. (2015) · PubMed · doi:10.3978/j.issn.1000-9604.2015.01.06 · Cited by 373
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367 · cited 1×
“Gut microbiota can promote the development and progression of CRC by different processes, including the induction of a chronic inflammatory state or immune response, altering stem cell dynamics, the biosynthesis of toxic and genotoxic metabolites, and affecting the host metabolism [20,21].”
BackgroundTargeting Inflammation in Cancer Prevention and Therapy
Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 354
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis
Sears, C. L., Geis, A. L., & Housseau, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72334 · Cited by 353
Chen, S., Zhu, J.-H., Wang, F., Huang, S.-Y., Xue, W.-Q., Cui, Z., He, J., & Jia, W.-H. (2015) · Chinese Journal of Cancer · doi:10.1186/s40880-015-0001-2 · Cited by 352
Colonic bacterial metabolites and human health
Russell, W. R., Hoyles, L., Flint, H. J., & Dumas, M.-E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.07.002 · Cited by 350
Role of Toll-like Receptors in Spontaneous Commensal-Dependent Colitis
Rakoff-Nahoum, S., Hao, L., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.010 · Cited by 344
Vegetarian Dietary Patterns and the Risk of Colorectal Cancers
Orlich, M. J., Singh, P. N., Sabaté, J., Fan, J., Sveen, L., Bennett, H., Knutsen, S. F., Beeson, W. L., Jaceldo-Siegl, K., Butler, T. L., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.59 · Cited by 334
Tong, L.-C., Wang, Y., Wang, Z.-B., Liu, W.-Y., Sun, S., Li, L., Su, D.-F., & Zhang, L.-C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00253 · Cited by 331
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Balamurugan, R., Rajendiran, E., George, S., Samuel, G. V., & Ramakrishna, B. S. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05490.x · Cited by 306
Baxter, N. T., Zackular, J. P., Chen, G. Y., & Schloss, P. D. (2014) · Microbiome · doi:10.1186/2049-2618-2-20 · Cited by 299
Fardini, Y., Wang, X., Témoin, S., Nithianantham, S., Lee, D., Shoham, M., & Han, Y. W. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07905.x · Cited by 291
Ciorba, M. A., Riehl, T. E., Rao, M. S., Moon, C., Ee, X., Nava, G. M., Walker, M. R., Marinshaw, J. M., Stappenbeck, T. S., & Stenson, W. F. (2012) · Gut · doi:10.1136/gutjnl-2011-300367 · Cited by 277
Bile acids as metabolic regulators
Li, T., & Chiang, J. Y. L. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000156 · Cited by 269
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
Probiotics, prebiotics and colorectal cancer prevention
Ambalam, P., Raman, M., Purama, R. K., & Doble, M. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.009 · Cited by 251
Biarc, J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh091 · Cited by 241
Wang, E. L., Qian, Z. R., Nakasono, M., Tanahashi, T., Yoshimoto, K., Bando, Y., Kudo, E., Shimada, M., & Sano, T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605558 · Cited by 238
Gamallat, Y., Meyiah, A., Kuugbee, E. D., Hago, A. M., Chiwala, G., Awadasseid, A., Bamba, D., Zhang, X., Shang, X., Luo, F., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.001 · Cited by 232
Thiele Orberg, E., Fan, H., Tam, A. J., Dejea, C. M., Destefano Shields, C. E., Wu, S., Chung, L., Finard, B. B., Wu, X., Fathi, P., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.53 · Cited by 219
Dl, E., Holubec, H., Wali, R. K., Jolley, C. S., BISSONNETTE, M., Bhattacharyya, A. K., Roy, H. K., Khare, S., & Brasitus, T. A. (1994) · PubMed · Cited by 209
He, X., Esteva, F. J., Ensor, J., Hortobagyi, G. N., Lee, M.-H., & Yeung, S.-C. J. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 207
Self-citationGeis, A. L., Fan, H., Wu, X., Wu, S., Huso, D. L., Wolfe, J. L., Sears, C. L., Pardoll, D. M., & Housseau, F. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0447 · Cited by 195
Xu, R., Wang, Q., & Li, L. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s4 · Cited by 193
ERK activation drives intestinal tumorigenesis in Apcmin/+ mice
Lee, S. H., Hu, L.-L., Gonzalez-Navajas, J., Seo, G. S., Shen, C., Brick, J., Herdman, S., Varki, N., Corr, M., Lee, J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2143 · Cited by 188
Adherent-invasive Escherichia coli and Crohnʼs disease
Barnich, N., & Darfeuille–Michaud, A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3280105a38 · Cited by 182
Duparc, T., Plovier, H., Marrachelli, V. G., Van Hul, M., Essaghir, A., Ståhlman, M., Matamoros, S., Geurts, L., Pardo-Tendero, M. M., Druart, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310904 · Cited by 177
Ge, Z., Rogers, A. B., Feng, Y., Lee, A., Xu, S., Taylor, N. S., & Fox, J. G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00939.x · Cited by 173
Bile acid: a potential inducer of colon cancer stem cells
Farhana, L., Nangia-Makker, P., Arbit, E., Shango, K., Sarkar, S., Mahmud, H., Hadden, T., Yu, Y., & Majumdar, A. P. N. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0439-4 · Cited by 173
Lowe, E. L., Crother, T. R., Rabizadeh, S., Hu, B., Wang, H., Chen, S., Shimada, K., Wong, M. H., Michelsen, K. S., & Arditi, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013027 · Cited by 172
Bernstein, A. M., Song, M., Zhang, X., Pan, A., Wang, M., Fuchs, C. S., Le, N. T., Chan, A. T., Willett, W. C., Ogino, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135959 · Cited by 169
Chen, C., Lin, W.-C., Kong, M., Shi, H. N., Walker, W. A., Lin, C., Huang, C.-T., Lin, Y., Jung, S.-M., & Lin, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004934 · Cited by 168
The human commensal Bacteroides fragilis binds intestinal mucin
Huang, J. Y., Lee, S. M., & Mazmanian, S. K. (2011) · Anaerobe · doi:10.1016/j.anaerobe.2011.05.017 · Cited by 166
Kuugbee, E. D., Shang, X., Gamallat, Y., Bamba, D., Awadasseid, A., Suliman, M. A., Zang, S., Ma, Y., Chiwala, G., Xin, Y., et al. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4238-7 · Cited by 163
He, X., Tu, S., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr020 · Cited by 161
Self-citationEnterotoxigenic Bacteroides fragilis: A potential instigator of colitis
Rabizadeh, S., Rhee, K., Wu, S., Huso, D. L., Gan, C. M., Golub, J. E., Wu, X., Zhang, M., & Sears, C. L. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20265 · Cited by 157
Im, E., & Martinez, J. D. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.483 · Cited by 154
Kim, Y., Lee, D. K., Kim, D., Cho, J., Yang, J. W., Chung, M.-J., Kim, K., & Ha, N. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1180-y · Cited by 153
Molecular phenotypes of colorectal cancer and potential clinical applications
Kocarnik, J., Shiovitz, S., & Phipps, A. I. (2015) · Gastroenterology report · doi:10.1093/gastro/gov046 · Cited by 145
Carcinogenesis and therapeutics: the microbiota perspective
Tsilimigras, M. C. B., Fodor, A., & Jobin, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.8 · Cited by 144
Regulatory CD4 T Cells Control the Size of the Peripheral Activated/Memory CD4 T Cell Compartment
Annacker, O., Burlen‐Defranoux, O., Pimenta‐Araujo, R., Cumano, A., & Bandeira, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3573 · Cited by 144
Barrasa, J. I., Olmo, N., Pérez-Ramos, P., Santiago-Gómez, A., Lecona, E., Turnay, J., & Lizarbe, M. A. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0633-x · Cited by 144
Gut Microbiome and Colorectal Adenomas
Dulal, S., & Keku, T. O. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000050 · Cited by 134
Evrard, B., Coudeyras, S., Dosgilbert, A., Charbonnel, N., Alamé, J., Tridon, A., & Forestier, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018735 · Cited by 133
Rodríguez‐Cabezas, M. E., Gálvez, J., Lorente, M., Concha, Á., Camuesco, D., Azzouz, S., Osuna, A., Redondo, L., & Zarzuelo, A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3263 · Cited by 128
The Enterobacterial Genotoxins: Cytolethal Distending Toxin and Colibactin
Taieb, F. E., Petit, C. R., Nougayrède, J., & Oswald, É. (2016) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0008-2016 · Cited by 126
Epithelial calcineurin controls microbiota-dependent intestinal tumor development
Peuker, K., Muff, S., Wang, J., Künzel, S., Bosse, E., Zeißig, Y., Luzzi, G., Basic, M., Strigli, A., Ulbricht, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4072 · Cited by 123
In vivovirulence properties of bacterial cytolethal-distending toxin
Ge, Z., Schauer, D. B., & Fox, J. G. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01173.x · Cited by 122
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
Yesudhas, D., Gosu, V., Anwar, M. A., & Choi, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00334 · Cited by 122
Prevention of colorectal cancer: How many tools do we have in our basket?
Roncucci, L., & Mariani, F. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.08.019 · Cited by 119
Regulation of Nur77 expression by β‐catenin and its mitogenic effect in colon cancer cells
Wu, H., Lin, Y., Li, W., Sun, Z., Gao, W., Zhang, H., Xie, L., Jiang, F., Qin, B. Y., Yan, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-166462 · Cited by 118
Kim, S. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000573 · Cited by 115
Ge, Z., Feng, Y., Whary, M. T., Nambiar, P. R., Xu, S., Ng, V., Taylor, N. S., & Fox, J. G. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3559-3567.2005 · Cited by 112
Cysteinyl leukotrienes and their receptors: Bridging inflammation and colorectal cancer
Savari, S., Vinnakota, K., Zhang, Y., & Sjölander, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.968 · Cited by 110
The complex interplay between inflammation, the microbiota and colorectal cancer
Arthur, J. C., & Jobin, C. (2013) · Gut Microbes · doi:10.4161/gmic.24220 · Cited by 110
Short Chain Fatty Acids and Colon Cancer
Augenlicht, L. H., Mariadason, J. M., Wilson, A., Arango, D., Yang, W., Heerdt, B. G., & Velcich, A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3804s · Cited by 106
Microbial-Derived Butyrate: An Oncometabolite or Tumor-Suppressive Metabolite?
Bultman, S. J., & Jobin, C. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.07.011 · Cited by 106
Biomarkers in precision therapy in colorectal cancer
Reimers, M. S., Zeestraten, E. C. M., Kuppen, P. J. K., Liefers, G., & van de Velde, C. J. �. (2013) · Gastroenterology report · doi:10.1093/gastro/got022 · Cited by 105
Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups
Hester, C. M., Jala, V. R., Langille, M. G., Umar, S., Greiner, K. A., & Haribabu, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i9.2759 · Cited by 104
Immune checkpoints and immunotherapy for colorectal cancer
Singh, P. P., Sharma, P. K., Krishnan, G., & Lockhart, A. C. (2015) · Gastroenterology report · doi:10.1093/gastro/gov053 · Cited by 101
Diet, Microbiota, and Colorectal Cancer
Akin, H., & Tozun, N. A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000252 · Cited by 100
Gut Microbiota and Colorectal Cancer
Yu, Y.-N., & Fang, J.-Y. (2015) · Gastrointestinal Tumors · doi:10.1159/000380892 · Cited by 92
Wali, R. K., Khare, S., Tretiakova, M., Cohen, G., Nguyễn, L., Hart, J. A. L., Wang, J., Wen, M., Ramaswamy, A., Joseph, L. J., et al. (2002) · PubMed · Cited by 89
Claësson, M. H., Bregenholt, S., Bonhagen, K., Thoma, S. J., Möller, P., Grusby, M. J., Leithäuser, F., Nissen, M. H., & Reimann, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3702 · Cited by 86
Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus
Pratt, J. S., Sachen, K. L., Wood, H. D., Eaton, K. A., & Young, V. B. (2006) · Infection and Immunity · doi:10.1128/iai.00503-06 · Cited by 85
Fung, K. Y. C., Brierley, G. V., Henderson, S., Hoffmann, P., McColl, S. R., Lockett, T. J., Head, R. J., & Cosgrove, L. J. (2011) · Journal of Proteome Research · doi:10.1021/pr1011125 · Cited by 83
Liu, D., Jiang, X., Zhou, L., Song, J., & Zhang, X. (2016) · Medicine · doi:10.1097/md.0000000000003342 · Cited by 79
O’Neill, A. M., Burrington, C. M., Gillaspie, E. A., Lynch, D. T., Horsman, M. J., & Greene, M. W. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.10.005 · Cited by 79
Ryz, N. R., Patterson, S. J., Zhang, Y., Ma, C., Huang, T., Bhinder, G., Wu, X., Chan, J., Glesby, A., Sham, H. P., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2012 · Cited by 78
Fusobacterium spp. and colorectal cancer: cause or consequence?
Keku, T. O., McCoy, A. N., & Azcárate-Peril, M. A. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.08.004 · Cited by 75
Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells
WANG, A.-C., Su, Q. B., Wu, F. X., Zhang, X., & Liu, P. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02070.x · Cited by 74
Centuori, S. M., & Martinez, J. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3190-7 · Cited by 68
Baek, M. K., Park, J. S., Park, J., Kim, M. H., Kim, H. D., Bae, W. K., Chung, I. J., Shin, B. A., & Jung, Y. D. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.030 · Cited by 66
Khare, S., Mustafi, R., Cerda, S., Yuan, W., Jagadeeswaran, S., Dougherty, U., Tretiakova, M., Samarel, A. M., Cohen, G., Wang, J., et al. (2008) · Nutrition and Cancer · doi:10.1080/01635580701883003 · Cited by 64
Cheng, K., Chen, Y., Zimniak, P., Raufman, J., Xiao, Y., & Frucht, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00115-1 · Cited by 59
Khare, S., Cerda, S., Wali, R. K., von Lintig, F. C., Tretiakova, M., Joseph, L. J., Stoiber, D., Cohen, G., Nimmagadda, K., Hart, J. A. L., et al. (2003) · PubMed · Cited by 59
Erdman, S. E., & Poutahidis, T. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.05.007 · Cited by 58
Centuori, S. M., Gomes, C. J., Trujillo, J., Borg, J. L., Brownlee, J., Putnam, C. W., & Martinez, J. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.006 · Cited by 58
Selmin, O. I., Fang, C., Lyon, A. M., Doetschman, T. C., Thompson, P. A., Martinez, J. D., Smith, J. W., Lance, P., & Romagnolo, D. F. (2015) · Journal of Nutrition · doi:10.3945/jn.115.216580 · Cited by 56
Leung, A., Tsoi, H., & Yu, J. Q. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1001745 · Cited by 53
Helicobacter pylori Protein–Specific Antibodies and Risk of Colorectal Cancer
Epplein, M., Pawlita, M., Michel, A., Peek, R. M., Cai, Q., & Blot, W. J. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0702 · Cited by 53
Belcheva, A., Irrazábal, T., & Martín, A. (2015) · BioEssays · doi:10.1002/bies.201400204 · Cited by 50
Kong, Y., Bai, P., Sun, H., Nan, K., Chen, N., & Qi, X. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.006 · Cited by 48
Nazareth, N., Magro, F., Machado, E., Ribeiro, T. G., Martinho, A., Rodrigues, P., Alves, R., Macedo, G. N., Grácio, D., Coelho, R., et al. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0420-3 · Cited by 47
Mitochondria, PPARs, and Cancer: Is Receptor‐Independent Action of PPAR Agonists a Key?
Scatena, R., Bottoni, P., & Giardina, B. (2008) · PPAR Research · doi:10.1155/2008/256251 · Cited by 46
Could microbial therapy boost cancer immunotherapy?
Snyder, A., Pamer, E. G., & Wolchok, J. D. (2015) · Science · doi:10.1126/science.aad7706 · Cited by 44
Dysbiosis of the fecal microbiota in the TNBS-induced Crohn’s disease mouse model
He, Q., Li, X., Liu, C., Su, L., Xia, Z., Li, X., Li, Y., Li, L., Yan, T., Feng, Q., et al. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7205-x · Cited by 39
Uchiyama, K., Sakiyama, T., Hasebe, T., Musch, M. W., Miyoshi, H., Nakagawa, Y., He, T., Lichtenstein, L., Naito, Y., Itoh, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep32094 · Cited by 39
Dong, L., Li, J., Liu, Y., Yue, W., & Luo, X. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06839.x · Cited by 35
Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?
Lopes, J. A. G., Borges-Canha, M., & Pimentel-Nunes, P. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i3.162 · Cited by 35
Khare, S., Cerda, S., Wali, R. K., von Lintig, F. C., Tretiakova, M., Stoiber, D., Cohen, G., Nimmagadda, K., Hart, J. A. L., Sitrin, M. D., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)83066-4 · Cited by 34
van Helden, S. F. G., van den Dries, K., Oud, M. M., Raymakers, R. A. P., Netea, M. G., van Leeuwen, F. N., & Figdor, C. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900764 · Cited by 29
Enterotoxigenic Bacteroides fragilis
Holton, J. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0018-7 · Cited by 29
Byrne, A.-M., Foran, E., Sharma, R., Davies, A., Mahon, C., O'Sullivan, J. N., O’Donoghue, D. P., Kelleher, D. P., & Long, A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq011 · Cited by 24
Abdel-Latif, M., Inoue, H., & Reynolds, J. V. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000198 · Cited by 19
Targeting Cell Metabolism in Cancer Patients
Heiden, M. G. V. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001210 · Cited by 18
Bacteria Moving into Focus of Human Cancer
Boccellato, F., & Meyer, T. F. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.016 · Cited by 17
Effects of DCA on Cell Cycle Proteins in Colonocytes
Ha, Y.-H., & Park, D.-G. (2010) · Journal of the Korean Society of Coloproctology · doi:10.3393/jksc.2010.26.4.254 · Cited by 13
Li, Y., Zhang, X., Wang, L., Zhou, Y., Hassan, J. S., & Li, M. (2015) · PubMed Central · Cited by 8
Cited by
Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J.-H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1103836 · Cited by 705
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Gut bacteria signaling to mitochondria in intestinal inflammation and cancer
Jackson, D. N., & Theiss, A. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1592421 · Cited by 312
Aging progression of human gut microbiota
Xu, C., Zhu, H., & Qiu, P. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1616-2 · Cited by 258
Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats
Behr, C., Slopianka, M., Haake, V., Strauss, V., Sperber, S., Kamp, H., Walk, T., Beekmann, K., Rietjens, I. M. C. M., & van Ravenzwaay, B. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.012 · Cited by 58
Metadata
- Authors
- Zou, S., Fang, L., & Lee, M.-H.
- Venue
- Gastroenterology Report
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-11
- Volume
- 6
- Issue
- 1
- Pages
- 1-12
- ISSN
- 2052-0034 (ISSN-L)
- OpenAlex
- W2762107171
- Cited by
- 280
- References
- 168
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.